Response Genetics' Q4 Revenues Rise 12 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics today reported that its revenues for the fourth quarter increased 12 percent year over year on the strength of its pharmaceutical client business.

The Los Angeles-based molecular diagnostic firm posted $5.5 million in revenues for the three months ended Dec. 31, 2012, compared to $4.9 million a year ago. Pharmaceutical client revenues rose 36 percent year over year, the company said, while revenues generated from Response DX genetic tests slid 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.